|
| Click here to download the full text |
| Citation of this paper:.[J].Chinese Journal of Clinical Medicine,2016,23(6):823-828 |
| Hits: 2627 |
| Download times: 1455 |
|
| Abstract:Stereotactic body radiotherapy (SBRT) and stereotactic ablative radiotherapy (SABR), methods of high local precision, have been widely used in early stage inoperable non small cell lung cancer (NSCLC) patients. In some clinical trials, the 3 year local control rate and 3 year survival rate were close to the effect of surgery, and had little effect on the pulmonary function of patients.This paper briefly reviews the clinical practice and research progress of SBRT/SABR in early stage NSCLC. |
| keywords:early stage lung cancer stereotactic body radiotherapy immunology |
| HTML View Full Text View/Add Comment Download reader |